Immunocore Holdings (IMCR) Other Non Operating Income (2023 - 2026)

Immunocore Holdings (IMCR) has reported Other Non Operating Income for 4 consecutive years, with $3.8 million the latest figure, recorded in Q1 2026.

• Quarterly Other Non Operating Income fell 29.62% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.1 million (down 8.81% YoY) and the FY2025 annual result came in at $19.7 million, up 38.95% from the prior year.
• Other Non Operating Income retreated to $3.8 million in Q1 2026 per IMCR's latest filing, from $4.5 million in the prior quarter.
• Over the last five years, Other Non Operating Income for IMCR reached as high as $11.2 million in Q3 2023 and fell as low as -$12.5 million in Q4 2023.
• A 4-year average of $1.7 million and a median of $4.4 million in 2024 frame the typical range for Other Non Operating Income.
• The largest YoY upside for Other Non Operating Income was 353.58% in 2025 against a maximum downside of 43.52% in 2025.
• Year by year, Other Non Operating Income stood at -$12.5 million in 2023, then surged by 107.96% to $993000.0 in 2024, then jumped by 353.58% to $4.5 million in 2025, then decreased by 14.54% to $3.8 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $3.8 million, $4.5 million, and $5.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.